Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-15 FUCHS HENRY J President, Worldwide R&D Shares withheld for taxes −12,101 $78.27 $947K 146,012
2022-03-15 FUCHS HENRY J President, Worldwide R&D Grant or award · Stock Option (Right to buy Common Stock) +35,830 35,830
2022-03-15 Mueller Brian EVP, Chief Financial Officer Grant or award +11,040 40,749
2022-03-15 Mueller Brian EVP, Chief Financial Officer Shares withheld for taxes −1,868 $78.27 $146K 38,881
2022-03-15 Mueller Brian EVP, Chief Financial Officer Grant or award · Stock Option (Right to buy Common Stock) +26,520 26,520
2022-03-15 Guyer Charles Greg EVP, Chief Technical Officer Grant or award +11,040 52,976
2022-03-15 Guyer Charles Greg EVP, Chief Technical Officer Shares withheld for taxes −920 $78.27 $72K 52,056
2022-03-15 Guyer Charles Greg EVP, Chief Technical Officer Grant or award · Stock Option (Right to buy Common Stock) +26,520 26,520
2022-03-15 Davis George Eric EVP, General Counsel Grant or award +11,040 79,000
2022-03-15 Davis George Eric EVP, General Counsel Shares withheld for taxes −8,290 $78.27 $649K 70,710
2022-03-15 Davis George Eric EVP, General Counsel Grant or award · Stock Option (Right to buy Common Stock) +26,520 26,520
2022-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +40,280 378,849
2022-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −38,306 $78.27 $3.0M 340,543
2022-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award · Stock Option (Right to buy Common Stock) +58,040 58,040
2022-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +11,940 77,163
2022-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Shares withheld for taxes −8,418 $78.27 $659K 68,745
2022-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award · Stock Option (Right to buy Common Stock) +28,670 28,670
2022-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +15,000 $37.46 $562K 353,569
2022-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Sale −15,000 $77.81 $1.2M 338,569
2022-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 85,000

Page 25 of 36 · 707 trades